Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Oriol Casanovas(Institut Català d'Oncologia), Douglas Hanahan(Ludwig Cancer Research), Gabriele Bergers(VIB-KU Leuven Center for Cancer Biology), Daniel J. Hicklin(C4 Therapeutics (United States))

Cancer Cell

October 1, 2005

10.1016/j.ccr.2005.09.005

Cited by 1,609

Related Papers

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

|Cancer Cell|2012|4.7k

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

|Cancer Cell|2009|2.3k

Induction of angiogenesis during the transition from hyperplasia to neoplasia

|Nature|1989|1.9k

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

|Nature Medicine|2001|1.7k

HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion

|Cancer Cell|2008|1.1k